CCL17 and chronic kidney disease: Our study provided a hypothesis that CCL17 had pro-fibrogenetic effects by demonstrating that its overexpression increased phenotype transformation and motility in renal tubule epithelial cells and ECM accumulation in vitro and in vivo, as well as being clinically useful as a novel biomarker that correlated negatively with renal function in CKD patients.